• Decrease font size
  • Default font           size
  • Increase font size
Pfizer Selects Prosonix Crystallization Technology PDF Print E-mail
Friday, 19 December 2008 11:47
Prosonix Ltd (Oxford, UK) is delighted to announce that Pfizer Global Manufacturing will implement Prosonix’ Prosonitron reactor and sonocrystallization process technology at Pfizer’s manufacturing facilities in Ireland. The Prosonitron technology will be used in the controlled crystallization and production of a number of Pfizer products, and follows an extended period of collaboration and testing with Pfizer Global Research and Development in Sandwich (UK).
Attachments:
FileFile size
Download this file (PROSONIX AND PFZER  PRESS RELEASE FINAL 16 SEPTEMBER 2008 PR.pdf)Pfizer press release101 Kb
Last Updated on Monday, 26 September 2011 22:25
 

Latest News

03 Feb 2012 - Geoff Down appointed as Chief Medical Officer
Prosonix Appoints Respiratory Drug Development Expert Dr Geoff Down as Chief Medical Officer Prosonix (Oxford, UK), an emerging pharmaceutical company developing a portfolio of enhanced respiratory...
More in: Latest

Events

Respiratory Drug Delivery 2012
10 October 2011 08:57
article thumbnai